Electroporation-Based Therapies for Cancer

From basics to clinical applications
Erscheinungsjahr 2014
ISBN: 978-1-907568-15-2
Verlag: Woodhead Publishing

Buch, Englisch, 352 Seiten, Gewicht: 670 g

Electroporation-Based Therapies for Cancer reviews electroporation-based clinical studies in hospitals for various cancer treatments, including melanomas, head and neck cancers, chest wall breast carcinomas, and colorectal cancers, as well as research studies in the lab using cell lines, primary cells, and animals.

Cancer kills about one American per minute, amounting to over 500,000 deaths in the United States and millions, worldwide, each year. There is a critical need for safe, effective, and affordable alternative treatment modalities, especially for inoperable, recurring, and chemo-resistant cancers, that do not respond well to current treatment regimen. An electrical-pulse-mediated, enhanced drug delivery technique known as electroporation is one way to effectively treat these patients.

This technique is especially suitable for low- and middle-income countries, where lack of infrastructure and resources leads to cancer diagnoses at late stages. This quick, safe, effective, economical, out-patient-based technique is a boon to these patients for palliative and other care with enhanced quality of life. This book features discussions by interdisciplinary authors-including practicing oncological surgeons, medical professionals, and academic and other researchers-of the basics and clinical medical applications of electroporation.

Autoren/Hrsg.

Sundararajan, Raji

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung

Inhaltsverzeichnis

- Dedication
- Epigraph
- List of figures and tables - Figures
- Tables

- Acknowledgments
- About the editor
- About the contributors
- Introduction - Motivation:

- Organization of the chapters
- Audience

- 1. Electrochemotherapy - A novel cancer treatment - Abstract:

- 1.1 Why electrochemotherapy?
- 1.2 References

- 2. Clinical electrochemotherapy for chest wall recurrence from breast cancer - Abstract:

- 2.1 Introduction
- 2.2 Scope of the problem
- 2.3 Treatment options for chest wall recurrence
- 2.4 Clinical experience with electrochemotherapy
- 2.5 Electrochemotherapy: the engineer's point of view
- 2.6 Conclusions and perspectives
- 2.7 Acknowledgments
- 2.8 References

- 3. Clinical electrochemotherapy for advanced superficial melanoma - Abstract:

- 3.1 Introduction
- 3.2 Therapeutic options in advanced melanoma
- 3.3 Clinical experience with electrochemotherapy
- 3.4 Conclusions and perspectives
- 3.5 References

- 4. Low and high voltage electrochemotherapy for breast cancer: an in vitro model study - Abstract:

- 4.1 Introduction
- 4.2 Anatomy of the breast and its cancer
- 4.3 Drug delivery issues
- 4.4 Chemotherapy issues
- 4.5 Common adverse effects of anticancer drugs
- 4.6 Anticancer drug resistance
- 4.7 Electroporation and electrochemotherapy
- 4.8 Materials and methods
- 4.9 Results and discussion
- 4.10 Conclusions
- 4.11 Acknowledgments
- 4.12 References

- 5. Why electroporation is a useful technique for cancer treatments - Abstract:

- 5.1 Introduction
- 5.2 What is electroporation (EP)?
- 5.3 Irreversible electroporation (IRE)
- 5.4 Electrochemotherapy (ECT)
- 5.5 Example of a hydrophilic agent used with electrochemotherapy
- 5.6 Local delivery by intratumoral injection versus systemic administration in EP
- 5.7 Prerequisites for effective ECT
- 5.8 ECT can overcome multidrug resistance
- 5.9 Intense nanosecond pulsed electric fields (nsPEFs)
- 5.10 Electroporation therapies can produce a reduction in blood flow to tumors
- 5.11 Properties of solid tumors
- 5.12 Why do tumors have increased susceptibility to (EP) permeabilizing pulses, compared to that of normal tissue?
- 5.13 Membrane composition and mineral concentrations of cancer cells affect the electrical properties
- 5.14 Oxygen levels vary in solid tumors
- 5.15 Glycolysis and pH
- 5.16 Conclusions
- 5.17 References

- 6. Electrically-enhanced proliferation control of cancer-stem-cells-like adult human mesenchymal stem cells - a novel modality of treatment - Abstract:

- 6.1 Introduction - stem cells
- 6.2 Mesenchymal stem cells
- 6.3 Cancer and cancer stem cells
- 6.4 Electrochemotherapy
- 6.5 In-vitro study of ECT on MSC
- 6.6 Materials and methods
- 6.7 Results and analyses
- 6.8 Discussion and conclusions
- 6.9 Future directions
- 6.10 Acknowledgments
- 6.11 References

- 7. An in vitro study of electroporation of leukemia and cervical cancer cells - Abstract:

- 7.1 Introduction
- 7.2 Materials and methods
- 7.3 Results and analysis
- 7.4 Conclusions
- 7.5 Acknowledgments
- 7.6 References

- 8. Low voltage nanosecond electroporation for breast cancer treatment: an in vitro study - Abstract:

- 8.1 Introduction
- 8.2 Materials and methods
- 8.3 Results and analysis
- 8.4 Discussion and conclusions
- 8.5 Acknowledgment
- 8.6 References

- 9. Low and high voltage electroporation of in vitro human ovarian adenocarcinoma cells - Abstract:

- 9.1 Introduction
- 9.2 Materials and methods
- 9.3 Results and analysis
- 9.4 Discussion and summary
- 9.5 Acknowledgments
- 9.6 References

- 10. Irreversible electroporation: a drug-free cancer treatment - Abstract:

- 10.1 Introduction
- 10.2 Materials and methods
- 10.3 Results and analyses
- 10.4 Discussion and conclusions
- 10.5 Acknowledgments
- 10.6 References

- 11. Targeted delivery of siRNA and other difficult to transfect molecules using electroporation: current status and future scope - Abstract:

- 11.1 Introduction
- 11.2 siRNA - a potential therapeutic tool for cancer treatment
- 11.3 siRNA-Gene targets in Cancer
- 11.4 Delivery of siRNA
- 11.5 Electroporation-based siRNA delivery
- 11.6 Summary and Future Scope
- 11.7 References

- 12. Electric field distribution study of breast tumors - Abstract:

- 12.1 Introduction
- 12.2 Electric field concepts
- 12.3 Electrical properties of cells
- 12.4 Finite element modeling
- 12.5 Electric field intensity used in clinical electrochemotherapy
- 12.6 Electrodes used
- 12.7 Thermal effects of electroporation
- 12.8 Simulation
- 12.9 Breast modeling
- 12.10 Results and discussion
- 12.11 Conclusions
- 12.12 References

- Index

Über Autor(innen)

Sundararajan, Raji
Dr Raji Sundararajan is an Associate Professor at the Electrical and Computer Engineering Technology Department, Purdue University, since fall 2006. She obtained her initial training on electroporation at Johns Hopkins Medical School and has been doing research on electroporation for the past several years. She has authored/co-authored over 130 publications and has won several research and teaching awards and honors. She was the recipient of the 2010 Indiana 'Women & Hi-Tech' award for 'Distinguished use of technology in healthcare Life Science' and won prestigious, one year (2010-11) fellowship to study regenerative medicine therapy using optoinjection and electroporation techniques at Purdue. She is a reviewer of NIH, NSF, US International Science & Technology Center, and US National Research Council proposals and various journals including International Journal of Cancer, Molecular Biotechnology, Journal of Biomedical Microdevices, Journal of Anticancer drugs, a number of IEEE Transactions and Journal of Electrostatics, etc. She is continually invited for keynote, workshop, panel moderator, invited talks, etc. for many conferences. Dr. Sundararajan, an IEEE Senior Member, is very active in various IEEE societies, including serving as Associate Editor of an IEEE Transactions and chairing two IEEE Standards task forces. A fellow of Institution of Engineers, India, Dr. Sundararajan is also the Conference Chair for IEEE International Conference on Electrical Insulation and Dielectric Phenomena (CEIDP - 2010 and 2011) and the President of Electrostatics Society of America (ESA-2009, 10, and 11) both with sessions on biomedical applications of electrical phenomena.

Dr Raji Sundararajan is an Associate Professor at the Electrical and Computer Engineering Technology Department, Purdue University, since fall 2006. She obtained her initial training on electroporation at Johns Hopkins Medical School and has been doing research on electroporation for the past several years. She has authored/co-authored over 130 publications and has won several research and teaching awards and honors. She was the recipient of the 2010 Indiana 'Women & Hi-Tech' award for 'Distinguished use of technology in healthcare Life Science' and won prestigious, one year (2010-11) fellowship to study regenerative medicine therapy using optoinjection and electroporation techniques at Purdue. She is a reviewer of NIH, NSF, US International Science & Technology Center, and US National Research Council proposals and various journals including International Journal of Cancer, Molecular Biotechnology, Journal of Biomedical Microdevices, Journal of Anticancer drugs, a number of IEEE Transactions and Journal of Electrostatics, etc. She is continually invited for keynote, workshop, panel moderator, invited talks, etc. for many conferences. Dr. Sundararajan, an IEEE Senior Member, is very active in various IEEE societies, including serving as Associate Editor of an IEEE Transactions and chairing two IEEE Standards task forces. A fellow of Institution of Engineers, India, Dr. Sundararajan is also the Conference Chair for IEEE International Conference on Electrical Insulation and Dielectric Phenomena (CEIDP - 2010 and 2011) and the President of Electrostatics Society of America (ESA-2009, 10, and 11) both with sessions on biomedical applications of electrical phenomena.